No. of studies | Study design | Quality assessment | No. of patients | Effect | Quality | |||||
---|---|---|---|---|---|---|---|---|---|---|
Risk of bias | Inconsistency | Indirectness | Imprecision | Other | Adjuvant | Control | Absolute (95% Cl) | |||
Total blood loss — systemic TXA | ||||||||||
5 | RCT | Not serious | Seriousa | Not serious | Not serious | No | 165 | 165 | MD − 18.05 (− 22.01; − 14.09) | + + + Moderate |
Total blood loss — topical TXA | ||||||||||
2 | RCT | Not serious | Seriousb | Not serious | Not serious | No | 129 | 129 | MD − 74.93 (− 88.79; − 61.07) | + + + Moderate |
Drainage output — topical TXA | ||||||||||
2 | RCT | Not serious | Not serious | Not serious | Not serious | No | 199 | 199 | MD 33.53 (14.29; 52.77) | + + + + High |
Haematoma –– topical TXA | ||||||||||
4 | RCT | Not serious | Not serious | Not serious | Not serious | No | 259 | 256 | MD 0.30 (0.07, 1.25) | + + + + High |